Form 4 for NRXP NRX Pharmaceuticals, Inc.
Accepted 2022-11-28 00:00:00 ET · period of report 2022-11-25 · accession 0001415889-22-011778 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2022-11-28 | 2022-11-25 | NRXP | VAN VOORHEES SETH | CFO | P - Purchase | $1.11 | +16.3K | 8,716 | New | +$18.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.001 per share | 2022-11-25 | P | A | 7,021 | $1.11 | 16,377 | I Shares purchased though 401(k) plan | — | — | |
| 2 | Common | Common Stock, par value $0.001 per share | 2022-11-25 | P | A | 600 | $1.10 | 9,316 | I Shares purchased though 401(k) plan | — | — | |
| 3 | Common | Common Stock, par value $0.001 per share | 2022-11-25 | P | A | 8,716 | $1.12 | 8,716 | I Shares purchased though 401(k) plan | — | — |